Skip to Main

Chrissy O’Brien is a core member of Boston Consulting Group’s Operations, Social Impact, Health Care, and Operations practices. 

Since joining BCG in 2007, Chrissy has worked extensively with pharmaceutical manufacturers on issues related to strategy and operations, including network design, supply chain organization and process design, transformation, make-buy analyses, and sourcing strategies. She has particularly deep experience in creating long- and medium-term strategies to optimize manufacturing networks, as well as in redesigning global supply chain organizations. 

Chrissy has also worked with clients across sustainable supply chains, provided divestiture evaluations and support, and led the post-merger integration of supply chain and logistics functions. She has helped numerous organizations implement adaptive strategies and redesign their strategic planning processes. 

Prior to joining BCG, Chrissy was an account executive at The Share Group.

AREAS OF EXPERTISE

EDUCATION

  • MBA, Tuck School of Business at Dartmouth
  • BA, Bryn Mawr College

Publications and Videos

" "

Boosting Your Bottom Line Through Decarbonization

Our fourth annual survey on carbon emissions found that the overall pace of decarbonization has slowed—but that leaders are realizing significant financial value.

Insights on the 2024 Health Care Innovation Landscape

Senior executives from venture capital, private equity, and the biopharma and medtech industries came together to discuss the key opportunities and challenges facing companies this year.

" "

The Lowest-Cost Path to Net Zero

By applying levers that reduce both carbon emissions and costs, industrial companies can generate savings to invest in further decarbonization initiatives.
MedTech Green Moment Is Here | rectangle

MedTech’s Green Moment Is Here

Medical technology companies play a big part in health care’s carbon emissions problem, both at the patient and provider levels. Fortunately, these firms can reduce their footprint affordably.
Biopharma Carve-Outs Are Tricky - rectangle

Biopharma Carve-Outs Are Tricky. Here’s How to Get Them Right.

Through carve-outs, companies can create value, streamline portfolios, and reduce complexity. But the ultimate success of a deal hinges on focused, proactive execution.
Real-World Supply Chain Resilience

Real-World Supply Chain Resilience

Efficiency in supply chain operations shouldn’t come at the expense of flexibility. Here’s how leading companies achieve both.
Aerial view of colorful shipping containers on a dock

Fight Supply Chain Emissions to Fight Climate Change

Even companies with modest direct-emissions footprints can make a global impact on decarbonization by implementing nine initiatives in their supply chains.
Your Supply Chain Needs a Sustainability Strategy

Your Supply Chain Needs a Sustainability Strategy

Companies seeking to reduce their environmental footprint should focus on one element of their operations in particular: their global supply chains.
Creating More Powerful Partnerships in Pharma Manufacturing|Hero

Creating More Powerful Partnerships in Pharma Manufacturing

Companies are eager to shift more of the production they outsource to trusted strategic partners, but doing that right takes analysis and planning.